Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Saved in:
| Title: | Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial. |
|---|---|
| Authors: | Smith AG; Department of Neurology, Virginia Commonwealth University, Richmond., Singleton JR; Department of Neurology, The University of Utah, Salt Lake City., Aperghis A; Department of Neurology, The University of Utah, Salt Lake City., Coffey CS; University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City., Creigh P; Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York., Cudkowicz M; Department of Neurology, Massachusetts General Hospital, Boston., Conwit R; Indiana University Department of Neurology and the National Institute of Neurological Disorders and Stroke, Rockville, Maryland., Ecklund D; University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City., Fedler JK; University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City., Gudjonsdottir A; University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City., Hauer P; Department of Neurology, The University of Utah, Salt Lake City., Herrmann DN; Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York., Kearney M; Department of Neurology, Massachusetts General Hospital, Boston., Kissel J; Department of Neurology, Ohio State University, Columbus., Klingner E; University of Iowa Clinical Trials Statistical and Data Management Center, Iowa City., Quick A; Department of Neurology, Ohio State University, Columbus., Revere C; Department of Neurology, The University of Utah, Salt Lake City., Stino A; Department of Neurology, University of Michigan, Ann Arbor. |
| Corporate Authors: | NeuroNEXT NN108 TopCSPN Study Team |
| Source: | JAMA neurology [JAMA Neurol] 2023 Dec 01; Vol. 80 (12), pp. 1334-1343. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Equivalence Trial |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2023.3711 |
